Bresler Swanepoel

Mr. Bresler Swanepoel

Nelson Mandela University
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
BSBresler Swanepoel
Bresler Swanepoel
George Mihai NitulescuGeorge Mihai Nitulescu
George Mihai Nitulescu
OOOctavian Tudorel Olaru
Octavian Tudorel Olaru
LVLuanne Venables
Luanne Venables
MVMaryna van de Venter
Maryna van de Venter
The use of some very well-known chemotherapeutic agents, such as cisplatin, is limited by toxicity in normal tissues and the development of drug resistance. In order to address drug resistance and the side-effects of anti-cancer agents, recent research has focused on finding novel combinations of anti-cancer agents with non-overlapping mechanisms of action. The cytotoxic effect of the synthetic 5-aminopyrazole derivative N-[[3-(4-bromophenyl)-1H-pyrazol-5-yl]-carbamothioyl]-4-chloro-benzamide (BC-7) was evaluated by the bis-Benzamide H 33342 trihydrochloride/propidium iodide (Hoechst 33342/PI) dual staining method against HeLa, MeWo, HepG2, Vero, and MRHF cell lines. Quantitative fluorescence image analysis was used for the elucidation of mechanism of action and synergism with cisplatin in HeLa cells. BC-7 displayed selective cytotoxicity towards HeLa cells (IC50 65.58 ± 8.40 μM) and induced apoptosis in a mitochondrial- and caspase dependent manner. This was most likely preceded by cell cycle arrest in the early M phase and the onset of mitotic catastrophe. BC-7 increased the cytotoxic effect of cisplatin in a synergistic manner with combination index (CI) values less than 0.9 accompanied by highly favourable dose reduction indices. Therefore, the results obtained support the implication that BC-7 has potential anti-cancer properties and that combinations of BC-7 with cisplatin should be further investigated for potential clinical applications.

30 December 2020 in Animals
Verified
Journal Article
Open access
PDF file
MVMaryna van de Venter
Maryna van de Venter
JDJenske Didloff
Jenske Didloff
SRShanika Reddy
Shanika Reddy
BSBresler Swanepoel
Bresler Swanepoel
SGSharlene Govender
Sharlene Govender
LVLuanne Venables
Luanne Venables
Zebrafish have become a popular alternative to higher animals in biomedical and pharmaceutical research. The development of stable mutant lines to model target specific aspects of many diseases, including diabetes, is well reported. However, these mutant lines are much more costly and challenging to maintain than wild-type zebrafish and are simply not an option for many research facilities. As an alternative to address the disadvantages of advanced mutant lines, wild-type larvae may represent a suitable option. In this review, we evaluate organ development in zebrafish larvae and discuss established methods that use wild-type zebrafish larvae up to seven days post fertilization to test for potential drug candidates for diabetes and its commonly associated conditions of oxidative stress and inflammation. This provides an up to date overview of the relevance of wild-type zebrafish larvae as a vertebrate antidiabetic model and confidence as an alternative tool for preclinical studies. We highlight the advantages and disadvantages of established methods and suggest recommendations for future developments to promote the use of zebrafish, specifically larvae, rather than higher animals in the early phase of antidiabetic drug discovery.

1 January 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
KRKhumo M. Rampa
Khumo M. Rampa
MVMaryna van de Venter
Maryna van de Venter
TKTrevor C. Koekemoer
Trevor C. Koekemoer
BSBresler Swanepoel
Bresler Swanepoel
LVLuanne Venables
Luanne Venables
GKGuy P.P. Kamatou
Guy P.P. Kamatou

Verified
Journal Article
Open access
PDF file
BSBresler Swanepoel
Bresler Swanepoel
LVLuanne Venables
Luanne Venables
OOOctavian Tudorel Olaru
Octavian Tudorel Olaru
George Mihai NitulescuGeorge Mihai Nitulescu
George Mihai Nitulescu
MVMaryna van de Venter
Maryna van de Venter
Anemone nemorosa is part of the Ranunculaceae genus Anemone (order Ranunculales) which comprises more than 150 species. Various parts of the plant have been used for the treatment of numerous medical conditions such as headaches, tertian agues, rheumatic gout, leprosy, lethargy, eye inflammation as well as malignant and corroding ulcers. The Anemone plants have been found to contain various medicinal compounds with anti-cancer, immunomodulatory, anti-inflammatory, anti-oxidant and anti-microbial activities. To date there has been no reported evidence of its use in the treatment of cancer. However, due to the reported abundance of saponins which usually exert anti-cancer activity via cell cycle arrest and the induction of apoptosis, we investigated the mode of cell death induced by an aqueous A. nemorosa extract by using HeLa cervical cancer cells. Cisplatin was used as a positive control. With a 50% inhibitory concentration (IC50) of 20.33 ± 2.480 µg/mL, treatment with A. nemorosa yielded a delay in the early mitosis phase of the cell cycle. Apoptosis was confirmed through fluorescent staining with annexin V-FITC. Apoptosis was more evident with A. nemorosa treatment compared to the positive control after 24 and 48 h. Tetramethylrhodamine ethyl ester staining showed a decrease in mitochondrial membrane potential at 24 and 48 h. The results obtained imply that A. nemorosa may have potential anti-proliferative properties.

9 April 2019 in Natural Product Research
Verified
Journal Article
Closed access
MNMutenta N. Nyambe
Mutenta N. Nyambe
DBDenzil R. Beukes
Denzil R. Beukes
MVMaryna Van De Venter
Maryna Van De Venter
BSBresler Swanepoel
Bresler Swanepoel
BHBuyiswa G. Hlangothi
Buyiswa G. Hlangothi
Flavonoids are a class of biologically active compounds with various proven nutraceutical benefits. In flavonoid C-glycosides, the aglycones are attached to sugar residues via cleavage-resistant C-C bonds which alter typical flavonoid pharmacokinetic properties. In these compounds, the combination of biological activities from the flavonoid moieties and sugar residues create unique and more diverse biological functions than those of O-glycosylated and unsubstituted flavonoids. Through a series of reverse phase chromatography techniques and various spectroscopic methods, the phytochemical investigation of Drimia altissima (L.F.) Ker Gawl., a specie from the Asparagaceae family, led to the isolation and chemical characterisation of a novel C-glucosylflavonoid, altissimin, with a unique apioglucoside arrangement to the apigenin aglycone. Altissimin was found to possess strong in vitro anti-proliferative activity against HeLa cervical cancer cells.

1 April 2020 in Phytochemistry Letters
Verified
Journal Article
Closed access
DMDaniel Zacharia Matata
Daniel Zacharia Matata
MMMainen Julius Moshi
Mainen Julius Moshi
FMFrancis Machumi
Francis Machumi
ONOlipa David Ngassapa
Olipa David Ngassapa
BSBresler Swanepoel
Bresler Swanepoel
MVMaryna van de Venter
Maryna van de Venter